Naproxen Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Naproxen Sodium Price Trend, Index and Forecast
Track the latest insights on naproxen sodium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Naproxen Sodium Prices Outlook Q3 2025
- USA: USD 42950/MT
- China: USD 41460/MT
- Germany: USD 44100/MT
- India: USD 32450/MT
- Brazil: USD 35200/MT
Naproxen Sodium Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the naproxen sodium prices in the USA reached 42950 USD/MT in September. The upward movement was primarily supported by stable downstream pharmaceutical demand and firm procurement from contract manufacturing organizations. Production costs remained elevated due to sustained prices of key intermediates and utilities, which limited the scope for price corrections. Import availability stayed moderate as suppliers prioritized domestic contractual commitments, tightening spot market volumes.
During the third quarter of 2025, the naproxen sodium prices in China reached 41460 USD/MT in September. Prices trended upward due to controlled operating rates at major pharmaceutical ingredient facilities and disciplined output management. Feedstock procurement costs remained firm, prompting producers to adjust quotations upward to protect margins. Export inquiries from overseas pharmaceutical formulators improved, absorbing a significant share of the available supply.
During the third quarter of 2025, the naproxen sodium prices in Germany reached 44100 USD/MT in September. The market experienced steady increased pressure due to strong demand from regulated pharmaceutical manufacturers and limited availability of alternative suppliers. Production costs stayed high as energy and compliance-related expenditures continued to influence manufacturing economics. Imports faced longer lead times, encouraging buyers to secure volumes early and at higher price levels. Inventory positions across distributors remained balanced, preventing aggressive discounting.
During the third quarter of 2025, the naproxen sodium prices in India reached 32450 USD/MT in September. Prices softened slightly as domestic supply availability improved following consistent production runs by local manufacturers. Demand from export-oriented pharmaceutical formulators remained steady but did not accelerate enough to absorb the additional volumes. Competitive pricing among suppliers intensified, especially in the spot market, leading to cautious price adjustments.
During the third quarter of 2025, the naproxen sodium prices in Brazil reached 35200 USD/MT in September. The market witnessed bullish momentum driven by consistent pharmaceutical consumption and reliance on imported material. Import costs remained firm due to stable global supplier pricing, which translated into higher domestic offers. Limited local production capacity kept buyers dependent on overseas sources, tightening availability in the regional market.
Naproxen Sodium Prices Outlook Q2 2025
- USA: USD 42232/MT
- China: USD 40568/MT
- Germany: USD 43066/MT
- India: USD 32945/MT
- Brazil: USD 34275/MT
During the second quarter of 2025, the naproxen sodium prices in the USA reached 42232 USD/MT in June. Market conditions were influenced by regular procurement from pharmaceutical manufacturers and healthcare formulators. Production planning remained aligned with confirmed contractual requirements. Raw material sourcing and compliance-related operational considerations shaped cost structures for domestic producers.
During the second quarter of 2025, the naproxen sodium prices in China reached 40568 USD/MT in June. Manufacturing activity was structured around domestic pharmaceutical demand and export commitments. Feedstock sourcing conditions supported cost planning for producers. Environmental oversight influenced operational discipline across production facilities. Export inquiries from overseas pharmaceutical companies contributed to market engagement.
During the second quarter of 2025, the naproxen sodium prices in Germany reached 43066 USD/MT in June. The market reflected demand from regulated pharmaceutical manufacturers requiring consistent quality compliance. Production economics incorporated energy procurement and regulatory adherence costs. Import flows supplemented domestic availability, supporting distribution requirements. Buyer procurement strategies prioritized long-term contracts and reliability of supply.
During the second quarter of 2025, the naproxen sodium prices in India reached 32945 USD/MT in June. Domestic manufacturing operations supported market availability through consistent production runs. Export-oriented pharmaceutical demand contributed to supplier order books. Competitive supplier presence influenced negotiation dynamics in both contract and spot segments. Feedstock availability and operational efficiencies supported production planning.
During the second quarter of 2025, the naproxen sodium prices in Brazil reached 34275 USD/MT in June. Market supply remained largely dependent on imported material. Overseas sourcing conditions and logistics considerations shaped landed cost structures. Pharmaceutical consumption supported routine procurement activity. Buyer purchasing followed established replenishment cycles.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing naproxen sodium prices.
Europe Naproxen Sodium Price Trend
Q3 2025:
The naproxen sodium price index in Europe reflected a firm upward trend supported by stable pharmaceutical manufacturing activity. Demand from regulated drug producers remained consistent, while compliance and quality assurance requirements sustained higher production costs. Import availability was balanced, with suppliers maintaining disciplined supply strategies. Inventory levels across distributors were adequate but not excessive, limiting downward price pressure. Energy and operational costs continued to influence pricing decisions, reinforcing a stable yet firm market environment across the region.
Q2 2025:
The naproxen sodium price index in Europe reflected the structural requirements of regulated pharmaceutical manufacturing and strict regulatory compliance frameworks. Producers operated under stringent quality, documentation, and traceability standards, which shaped overall production planning and cost allocation. Energy procurement, labor compliance, and operational overheads were incorporated into manufacturing economics across the region.
This analysis can be extended to include detailed naproxen sodium price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Naproxen Sodium Price Trend
Q3 2025:
The naproxen sodium price index in North America showed gradual strengthening. Pharmaceutical consumption remained steady, and manufacturers maintained controlled output levels. Import competition was moderate, allowing domestic producers to retain pricing leverage. Cost structures remained firm due to operational and regulatory considerations. Buyer purchasing behavior focused on contractual security rather than spot opportunities, supporting sustained price firmness across the region.
Q2 2025:
The naproxen sodium keyword price index in North America was shaped by predictable pharmaceutical demand patterns and structured production planning by manufacturers. Producers aligned output closely with confirmed orders from branded and generic drug formulators. Import participation played an important role in sourcing strategies, offering buyers diversified supply options while maintaining compliance with regional regulatory standards. Operational cost structures reflected quality control requirements, validation procedures, and manufacturing compliance obligations.
Specific naproxen sodium historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Naproxen Sodium Price Trend
Q3 2025:
As per the naproxen sodium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the naproxen sodium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on naproxen sodium prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Naproxen Sodium Price Trend
Q3 2025:
Asia Pacific markets reflected mixed trends influenced by production dynamics and export demand. Manufacturing hubs maintained disciplined output, while downstream pharmaceutical demand remained steady. Competitive supplier behavior moderated aggressive price increases. Logistics operations supported smooth material flow, resulting in a fluctuating regional pricing environment.
Q2 2025:
Asia Pacific naproxen sodium markets were influenced by regional manufacturing output, export participation, and domestic pharmaceutical usage. Major production hubs operated in alignment with both local demand and international supply commitments. Export-oriented manufacturers balanced overseas shipments with domestic pharmaceutical requirements. Supplier competition across the region shaped negotiation dynamics, particularly in contract-based transactions.
This naproxen sodium price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Naproxen Sodium Price Trend
Q3 2025:
During the third quarter of 2025, Latin American naproxen sodium prices trended upward due to import reliance and steady pharmaceutical consumption. Limited domestic manufacturing capacity and consistent buyer procurement supported firm pricing. Inventory replenishment cycles contributed to sustained demand, reinforcing the upward regional trend.
Q2 2025:
Latin American naproxen sodium pricing reflected a strong reliance on imported pharmaceutical ingredients and regular procurement by healthcare manufacturers. Limited regional production capacity necessitated sourcing from international suppliers that met regulatory and quality standards. Buyer purchasing followed established replenishment cycles aligned with pharmaceutical production planning and healthcare demand forecasts.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Naproxen Sodium Pricing Report, Market Analysis, and News
IMARC's latest publication, “Naproxen Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the naproxen sodium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of naproxen sodium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed naproxen sodium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting naproxen sodium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Naproxen Sodium Industry Analysis
The global naproxen sodium market size reached 16,890.7 Tons in 2025. By 2034, IMARC Group expects the market to reach 25,958.4 Tons, at a projected CAGR of 4.89% during 2026-2034. The market is primarily driven by the expanding pharmaceutical manufacturing, sustained demand for pain management therapies, and increasing penetration of generic drug formulations.
Latest News and Developments:
- September 2025: Maxwellia, a consumer healthcare company, introduced the first over-the-counter naproxen-based medicine in the UK pharmacy market for the treatment of acute musculoskeletal pain. The product, Naprosyn Pain Relief 250 mg gastro-resistant tablets, represented the first single-ingredient oral analgesic for acute back, muscle, and joint pain to become available without prescription in more than ten years. Designed for pharmacy sale, the formulation delivered sustained pain relief with a dosing duration extending up to twelve hours, addressing the need for longer-lasting management of musculoskeletal discomfort.
Product Description
Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that is used for pain relief and inflammation reduction. It is the sodium salt of naproxen, enhancing its solubility and absorption in the gastrointestinal tract. This drug is available in various forms, including tablets, capsules, and liquid suspensions. It exhibits unique properties, including potent anti-inflammatory, analgesic, and antipyretic effects. It finds application in the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, dysmenorrhea, mild to moderate pain, dental pain, and fever reduction.
Naproxen sodium offers numerous benefits, such as its effectiveness in reducing inflammation and pain, relatively long duration of action, availability in over-the-counter (OTC) and prescription forms, quick onset of action, well-documented safety profile, efficacy in chronic pain management, suitability for acute pain, reduction of fever, ease of administration, and its role in improving quality of life.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Naproxen Sodium |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Naproxen Sodium Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of naproxen sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting naproxen sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The naproxen sodium price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.